Market Scope uses a multi-source methodology when preparing our annual and quarterly reports. We incorporate surgeon surveys, our extensive database of physicians and surgery centers, disease models, clinical studies, financial reports, and more. Our wide-ranging knowledge of products and technology and our comprehensive network of industry contacts also contribute to our coverage on the ophthalmic industry.
The “Ophthalmic Deals Report” analyzes recent investments in ophthalmology and provides information for evaluation of the market value of various technologies, as evidenced by investment amounts and sales prices for new ophthalmic ventures.
This report covers recent investments in ophthalmic ventures, including venture capital, public offerings, licensing, milestone payments, sales of products and companies, and major borrowings. The report is designed for entrepreneurs, investors, venture capitalists, and companies looking to invest in the ophthalmic market—and companies looking to raise funds.
Our coverage of the US glaucoma surgery market includes a quarterly surveying process that targets and collects data from glaucoma surgeons. The resulting data are analyzed and presented in our US Glaucoma Surgery Quarterly Updates. These updates are designed to improve your decision-making process with an assessment of current market conditions and the identification of significant market trends -- including a variety of vital practice of medicine issues, doctors’ evaluations of pharmaceuticals and surgical equipment, product use and market share, product adoption plans, and the identification of significant trends in the marketplace for the treatment of glaucoma.
Each update includes full-year forecasts, comparisons with prior years, and trend analysis.
Market Scope’s 2021 Glaucoma Disease Model offers extensive country-level prevalence data and five-year forecasts for glaucoma by type and by age group for all countries with a population over a million.
This proprietary model takes into consideration the latest clinical research and demographic projections on a global scale and can be customized by geography and disease category to meet clients’ diverse needs. Disease models can be used to evaluate target markets for clinical-stage and commercial-stage products and gain insights into the volume and demographics of diseased populations.
The “2022 United States Cataract Atlas” provides a geographic analysis of the conventional and premium cataract surgery opportunity in 85 US metropolitan areas. Market Scope’s proprietary MedOp Index™ Analysis examines market potential and provides a benchmark against other metros. The atlas offers strategic insights into the top potential markets in the US, which companies often use throughout the development and commercialization processes to identify ideal clinical trial locations, develop launch strategies, define sales territories, allocate resources, and optimize sales and marketing initiatives.
Our coverage of the refractive surgery market includes a quarterly surveying process that targets and collects data from US refractive surgeons. The resulting data are analyzed and presented in our US Refractive Surgery Quarterly Updates. These updates are designed to improve your decision-making process with the most accurate assessment of current market conditions and the identification of significant market trends.
Our coverage of the cataract surgery market includes a quarterly surveying process that targets and collects data from US cataract surgeons. The resulting data are analyzed and presented in our US Cataract Surgery Quarterly Updates. These updates are designed to improve your decision-making process with the most accurate assessment of current market conditions and the identification of significant market trends.
The “2022 Retinal Surgical Device Market Report” provides in-depth analysis of the global retinal device market, examining the market’s size and growth, as well as identifying important developments that may shape its future. The analysis focuses on the 2022 market and forecasts market growth and evolution through 2027. Additionally, 35 retina device companies are profiled, with discussion of their products, strategic market position, background, and outlook.
The “2022 Glaucoma Pharmaceuticals Market Report” analyzes the global and regional markets for glaucoma pharmaceuticals, identifying important trends and key factors for future success. The report provides forecasts through 2027 for branded prostaglandins, generic prostaglandins, beta blockers, carbonic anhydrase inhibitors, alpha agonists, fixed combo drugs, NO-donating compounds, and rho-kinase inhibitors. The report also extensively discusses pipeline products, covering over 30 drug candidates that are currently under development. Additionally, 29 glaucoma pharmaceutical companies are profiled, discussing their products, strategic market position, background, and outlook.
The “2021 Optical Coherence Tomography Market Report” provides a comprehensive analysis of the global market for OCT imagers and forecasts market performance over the next five years. It analyzes the market drivers for the OCT segment, including providers, related diseases, competitive forces, and market trends. Market estimates are divided into six categories: basic OCT models, advanced OCT models, combination OCT/fundus systems, combination OCT/SLO systems, intraoperative OCT, and OCTA. Estimates are included for unit sales, installed equipment base, and average prices. Additionally, 12 OCT manufacturers are profiled, with discussion of their products, strategic market position, background, and outlook.
This new first-edition "2021 Annual US Diagnostic Equipment Survey Report" was designed to help market competitors better understand industry dynamics, gain important insights into leading trends, and explore surgeons’ opinions regarding current and future technologies.
Market Scope surveyed US ophthalmologists during November and December 2021 to measure adoption of diagnostic technology, purchasing plans of capital equipment, and insight into the latest market trends.
US ophthalmologists from all surgical specialties (cataract, refractive, cornea, retina, glaucoma, and comprehensive) who self-registered on market-scope.com were invited to participate in this sponsored survey on diagnostics.
In addition to our standard comprehensive reports, we also leverage our expert knowledge of the ophthalmic industry to design custom research that enhances strategy and operations for our clients. Our unique experience makes us a trusted partner in defining problems and executing solutions.
Common project types include custom data analysis, surveying and/or interviewing of ophthalmologists, focus groups, territory analyses, and other primary research initiatives -- but each project is custom designed to meet each specific clients' needs.
Please contact us for an individualized project consultation.
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.